Insights into Migraine Treatments offers a comprehensive overview to guide the selection of the most appropriate therapy for each patient within the landscape of migraine care. It explores the full spectrum of available treatments and their mechanisms of action, while addressing the challenges of individualized therapeutic decision-making. By presenting essential data on efficacy, safety, and biomarkers of treatment response, this book serves as a practical resource for tailoring interventions to patient-specific needs. With its solution-oriented approach, it is a valuable reference for clinicians and researchers striving to advance migraine management.
Covering topics from the clinical characteristics of migraine to acute therapies, pharmacological and nonpharmacological preventive strategies, and clinical, neuroimaging, and neurophysiological biomarkers, this book is designed to meet the complex and evolving needs of migraine patients.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. ix 7. Chapter 1. Clinical manifestations of migraine - p. 1 8. Chapter 2. Why, when, and how to treat migraine patients? - p. 13 9. Chapter 3. Acute treatments: nonsteroidal anti-inflammatory drugs, ergot alkaloids, triptans, and ditans - p. 33 10. Chapter 4. Acute treatments: neuromodulation and peripheral nerve blocks - p. 51 11. Chapter 5. Oral preventive treatments: antidepressants, antihypertensives, anticonvulsants, betablockers, and calcium channel blockers - p. 81 12. Chapter 6. Preventive treatments: onabotulinumtoxinA and peripheral nerve blocks - p. 99 13. Chapter 7. Nonpharmacological approaches in migraine prevention: neuromodulation, nutraceuticals, and behavioral approaches - p. 123 14. Chapter 8. Why target the calcitonin gene-related peptide pathway: Receptors, intracellular pathways, and its role in migraine pathophysiology - p. 141 15. Chapter 9. Gepants - p. 157 16. Chapter 10. Anti-CGRP monoclonal antibodies - p. 175 17. Chapter 11. Biomarkers of treatment response - p. 205 18. Chapter 12. Migraine treatments: what have we learned from neuroimaging? - p. 221 19. Chapter 13. Migraine treatments: what have we learned from neurophysiology? - p. 241 20. Chapter 14. Treatments to use in special circumstances: children, pregnancy, elderly - p. 257 21. Chapter 15. Unmet needs and future perspectives - p. 287 22. Index - p. 299
Insights into Migraine Treatments offers a comprehensive overview to guide the selection of the most appropriate therapy for each patient within the landscape of migraine care. It explores the full spectrum of available treatments and their mechanisms of action, while addressing the challenges of individualized therapeutic decision-making. By presenting essential data on efficacy, safety, and biomarkers of treatment response, this book serves as a practical resource for tailoring interventions to patient-specific needs. With its solution-oriented approach, it is a valuable reference for clinicians and researchers striving to advance migraine management.
Covering topics from the clinical characteristics of migraine to acute therapies, pharmacological and nonpharmacological preventive strategies, and clinical, neuroimaging, and neurophysiological biomarkers, this book is designed to meet the complex and evolving needs of migraine patients.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. ix 7. Chapter 1. Clinical manifestations of migraine - p. 1 8. Chapter 2. Why, when, and how to treat migraine patients? - p. 13 9. Chapter 3. Acute treatments: nonsteroidal anti-inflammatory drugs, ergot alkaloids, triptans, and ditans - p. 33 10. Chapter 4. Acute treatments: neuromodulation and peripheral nerve blocks - p. 51 11. Chapter 5. Oral preventive treatments: antidepressants, antihypertensives, anticonvulsants, betablockers, and calcium channel blockers - p. 81 12. Chapter 6. Preventive treatments: onabotulinumtoxinA and peripheral nerve blocks - p. 99 13. Chapter 7. Nonpharmacological approaches in migraine prevention: neuromodulation, nutraceuticals, and behavioral approaches - p. 123 14. Chapter 8. Why target the calcitonin gene-related peptide pathway: Receptors, intracellular pathways, and its role in migraine pathophysiology - p. 141 15. Chapter 9. Gepants - p. 157 16. Chapter 10. Anti-CGRP monoclonal antibodies - p. 175 17. Chapter 11. Biomarkers of treatment response - p. 205 18. Chapter 12. Migraine treatments: what have we learned from neuroimaging? - p. 221 19. Chapter 13. Migraine treatments: what have we learned from neurophysiology? - p. 241 20. Chapter 14. Treatments to use in special circumstances: children, pregnancy, elderly - p. 257 21. Chapter 15. Unmet needs and future perspectives - p. 287 22. Index - p. 299
